Oncology Ventures LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Oncology Ventures LLC
CRD #334395
SEC #802-132161
CIK #
AUM
Employees
Phone516-851-2311
Address
Source [IAPD] [Website] [LinkedIn]
Total AUM ($)
1.00.80.60.40.20.02010201520212027
Type Form D Funds Date Sold AUM
VC Oncology Ventures Fund II-A LP 2026-02-25 9.1 M
VC Oncology Ventures Fund II LP 2026-02-25 37.1 M
VC Nexcure NOV 2025 A Series of CGF2021 LLC 2026-02-18 0.1 M
VC RISA NOV 2024 A Series of CGF2021 LLC 2026-02-18 0.5 M
VC RISA Series A NOV 2025 Series of CGF2021 LLC 2026-02-18 0.4 M
VC TONO Health NOV 2024 A Series of CGF2021 LLC 2026-02-18 0.3 M
VC Concr Jun 2023 A Series of CGF2021 LLC [2025-02-10] 0.4 M 0.4 M
Offered $410,990 · Filed 2023-10-30 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC Health Universe Dec 2023 A Series of CGF2021 LLC [2025-02-10] 0.2 M 0.2 M
Offered $246,000 · Filed 2024-02-14 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC Oncology Ventures Fund I-A LP [2025-02-10] 5.0 M 7.0 M
Filed 2024-05-14 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $10,000 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC Oncology Ventures Fund I LP [2025-02-10] 21.2 M 25.4 M
Offered $40,000,000 · Filed 2024-05-14 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $10,000 · Remaining $18,838,000 · Duration One year or less · Revenue Decline to Disclose
VC Vivor Care Jan 2023 A Series of CGF2021 LLC [2025-02-10] 0.3 M 0.3 M
Offered $278,000 · Filed 2023-02-07 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors Role # Filings # Firms 2011 - 2026
Sydecar Director 4786 74
Taylor Hughes Executive Officer 1540 42
Ben Freeberg Executive Officer 4 2
Oncology Ventures LLC Executive Officer 2 1
Oncology Ventures GP I LLC Executive Officer 2 1
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com